STOCK TITAN
  1. Home
  2. Sec-filings
  3. JUNS
  4. [EFFECT] JUPITER NEUROSCIENCES, INC. SEC Filing

[EFFECT] JUPITER NEUROSCIENCES, INC. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
EFFECT

Rhea-AI Filing Summary

Analyzing...
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: December 11, 2025 5:30 P.M.
Form: S-1
CIK: 0001679628
Company Name: JUPITER NEUROSCIENCES, INC.
File Number: 333-291832

Source: View Original Filing on SEC EDGAR

JUPITER NEUROSCIENCES, INC.

NASDAQ:JUNS

View JUNS Stock Overview →

JUNS Rankings

#6340 Ranked by Market Cap
N/A Ranked by Dividends

JUNS Latest News

Mar 2, 2026
Jupiter Neurosciences to Present at BIO Investment and Growth Summit 2026
Feb 25, 2026
Jupiter Neurosciences Invited to Present Clinical and Commercial Progress at Investor Dinner at Mar-a-Lago
Feb 23, 2026
Jupiter Neurosciences Amends Yorkville Installment Provisions to Align Capital With Clinical and Commercial Execution
Jan 28, 2026
Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users
Jan 27, 2026
Jupiter Neurosciences Presenting at the 3rd Annual DealFlow Discovery Conference

JUNS Latest SEC Filings

Feb 27, 2026
[8-K] JUPITER NEUROSCIENCES, INC. Reports Material Event
Feb 20, 2026
[8-K] JUPITER NEUROSCIENCES, INC. Reports Material Event
Nov 20, 2025
[8-K/A] JUPITER NEUROSCIENCES, INC. Amends Material Event Report
Nov 14, 2025
[10-Q] JUPITER NEUROSCIENCES, INC. Quarterly Earnings Report
Nov 6, 2025
[ARS] JUPITER NEUROSCIENCES, INC. SEC Filing

JUNS Stock Data

12.07M
15.80M
Biotechnology
Pharmaceutical Preparations
Link
United States
JUPITER